Primary Effusion Lymphoma

Authors

  • Nitish Singh Nandu Department of Internal Medicine, Rosalind Franklin University of Medicine Author
  • Swetha Paduri Department of Internal Medicine, Rosalind Franklin University of Medicine Author
  • Hazes Husam Department of Internal Medicine, Rosalind Franklin University of Medicine Author
  • Aravind Reddy Kuchkuntla Department of Internal Medicine, Rosalind Franklin University of Medicine Author

DOI:

https://doi.org/10.47363/JONRR/2021(2)132

Keywords:

Lymphoma, Primary Effusion

Abstract

Primary effusion lymphoma (PEL) is a type of B-cell NonHodgkin’s lymphoma (NHL) [1]. It was first described in 1989 as an AIDS-related lymphoma in patients with a human immunodeficiency virus (HIV) infection presenting with weakness and cachexia with a large malignant pleural effusion [2]. PEL was later found to be associated with kaposi sarcoma-associated herpesvirus (KSHV) or Human Herpes Virus 8 (HHV 8) [3,4]. PEL was later classified as a mature large B cell neoplasm without a detectable tumor mass by the World Health Organization [5].

Author Biographies

  • Nitish Singh Nandu, Department of Internal Medicine, Rosalind Franklin University of Medicine

    Department of Internal Medicine, Rosalind Franklin University of Medicine

  • Swetha Paduri, Department of Internal Medicine, Rosalind Franklin University of Medicine

    Department of Internal Medicine, Rosalind Franklin University of Medicine 

  • Hazes Husam, Department of Internal Medicine, Rosalind Franklin University of Medicine

    Department of Internal Medicine, Rosalind Franklin University of Medicine 

  • Aravind Reddy Kuchkuntla, Department of Internal Medicine, Rosalind Franklin University of Medicine

    Department of Internal Medicine, Rosalind Franklin University of Medicine 

Downloads

Published

2021-05-10

Issue

Vol. 2 No. 3 (2021): Volume 2 Issue 3

Section

Articles